Drug FDA Class II Terminated Failed specifications
clomiPRAMINE Hydrochloride Capsules USP 25 mg, 100 count bottles, 5801 Pelican Bay Boulevard, Suite 500, Naples, Florida 34108, NDC# 68180-492-01
Lupin Pharmaceuticals Inc. Published Jul 30, 2025
Risk level
Class IIMay cause a temporary or reversible health problem; slight chance of serious harm.
Severity score 55/100
What should you do?
- Check whether you have this product, using the lot codes, UPCs, and dates listed below.
- Do not eat, serve, or sell the affected product.
- Return it to the place of purchase for a refund, or throw it away in a sealed bag so people and animals can’t get to it.
- Contact Lupin Pharmaceuticals Inc. or your place of purchase with questions, and see the source record below for full details.
Reason for recall
Failed Impurities/Degradation Specifications: an out of specification result observed in degradation product test (any unspecified degradation product) during retention sample testing at expiry.
Hazards
Failed Degradation Product Specification · primary
Affected products (1)
clomiPRAMINE Hydrochloride Capsules USP 25 mg, 100 count bottles, 5801 Pelican Bay Boulevard, Suite 500, Naples, Florida 34108, NDC# 68180-492-01
CLOMIPRAMINE HYDROCHLORIDE · 2,724 bottles
NDC: 68180-492, 68180-493, 68180-494, 68180-492-01, 68180-492-07, 68180-492-09, 68180-492-06, 68180-493-01, 68180-493-07, 68180-493-09, 68180-493-06, 68180-494-01, 68180-494-07, 68180-494-09, 68180-494-06
Lot codes: M300464
Code info: Lot # M300464, exp. date June, 2025
Affected areas
Nationwide
Timeline
- InitiatedJun 27, 2025
- PublishedJul 30, 2025
- TerminatedJan 5, 2026
- Recall number
- D-0537-2025
- Agency
- U.S. Food and Drug Administration
- Country
- US
FDA records come from the openFDA drug enforcement-report dataset — the agency's full weekly enforcement list. Most entries are not issued as consumer press releases, so they won't appear on fda.gov/recalls or in a web search. The source record link above resolves this exact recall by its number.